1. Pembrolizumab in hemodialysis patients. Is it safe?
- Author
-
Guzmán Vasquez M, Zapata Balcázar AP, Gaitán Tocora DG, Álamo Caballero C, Rodríguez Palomares JR, Sánchez Heras M, and de Arriba de la Fuente G
- Subjects
- Adenocarcinoma, Clear Cell secondary, B7-H1 Antigen metabolism, Bone Neoplasms secondary, Glomerulonephritis, IGA therapy, Graft Rejection immunology, Humans, Kidney Transplantation, Lung Neoplasms pathology, Male, Middle Aged, Peritoneal Dialysis, Reoperation, Adenocarcinoma, Clear Cell drug therapy, Antibodies, Monoclonal, Humanized adverse effects, Antineoplastic Agents, Immunological adverse effects, Bone Neoplasms drug therapy, Lung Neoplasms drug therapy, Ribs
- Published
- 2020
- Full Text
- View/download PDF